A report on Endometrial cancer and Raloxifene
Raloxifene does not cause breast tenderness, endometrial hyperplasia, menstrual bleeding, or endometrial cancer.
- RaloxifeneRaloxifene, a similar drug, did not raise the risk of endometrial cancer.
- Endometrial cancer4 related topics with Alpha
Tamoxifen
3 linksSelective estrogen receptor modulator used to prevent breast cancer in women and treat breast cancer in women and men.
Selective estrogen receptor modulator used to prevent breast cancer in women and treat breast cancer in women and men.
Tamoxifen increases the risk of postmenopausal bleeding, endometrial polyps, hyperplasia, and endometrial cancer; using tamoxifen with an intrauterine system releasing levonorgestrel might increase vaginal bleeding after 1 to 2 years, but reduces somewhat endometrial polyps and hyperplasia, but not necessarily endometrial cancer.
In 2006, the large STAR clinical study concluded that raloxifene is also effective in reducing the incidence of breast cancer.
Breast cancer
2 linksCancer that develops from breast tissue.
Cancer that develops from breast tissue.
The medications tamoxifen or raloxifene may be used in an effort to prevent breast cancer in those who are at high risk of developing it.
The selective estrogen receptor modulators reduce the risk of breast cancer but increase the risk of thromboembolism and endometrial cancer.
Estrogen receptor
2 linksEstrogen receptors (ERs) are a group of proteins found inside cells.
Estrogen receptors (ERs) are a group of proteins found inside cells.
Selective estrogen receptor modulators (e.g., tamoxifen, clomifene, raloxifene)
Estrogen and the ERs have also been implicated in breast cancer, ovarian cancer, colon cancer, prostate cancer, and endometrial cancer.
Menopause
1 linksTime in women's lives when menstrual periods stop permanently, and they are no longer able to bear children.
Time in women's lives when menstrual periods stop permanently, and they are no longer able to bear children.
A period-like flow during postmenopause, even spotting, maybe a sign of endometrial cancer.
The most commonly prescribed SERMs are raloxifene and tamoxifen.